Previous Article | Next Article 
Infect Immun, January 1998, p. 330-335, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Use of Green Fluorescent Protein To Assess Urease
Gene Expression by Uropathogenic Proteus mirabilis during
Experimental Ascending Urinary Tract Infection
Hui
Zhao,1
Richard B.
Thompson,2
Virginia
Lockatell,3
David E.
Johnson,3 and
Harry
L. T.
Mobley1,*
Department of Microbiology and
Immunology,1
Department of Biochemistry
and Molecular Biology,2 and
Division of
Infectious Diseases,3 University of Maryland
School of Medicine, Baltimore, Maryland 21201
Received 7 August 1997/Returned for modification 24 September
1997/Accepted 7 October 1997
 |
ABSTRACT |
Proteus mirabilis, a cause of complicated urinary tract
infection, expresses urease when exposed to urea. While it is
recognized that the positive transcriptional activator UreR induces
gene expression, the levels of expression of the enzyme during
experimental infection are not known. To investigate in vivo expression
of P. mirabilis urease, the gene encoding green
fluorescent protein (GFP) was used to construct reporter fusions.
Translational fusions of urease accessory gene ureD, which
is preceded by a urea-inducible promoter, were made with
gfp (modified to express S65T/V68L/S72A [B. P. Cormack et al. Gene 173:33-38, 1996]). Constructs were confirmed by
sequencing of the fusion junctions. UreD-GFP fusion protein was induced
by urea in both Escherichia coli DH5
and P. mirabilis HI4320. By using Western blotting with antiserum raised
against GFP, expression level was shown to correlate with urea
concentration (tested from 0 to 500 mM), with highest induction at 200 to 500 mM urea. Fluorescent E. coli and P. mirabilis bacteria were observed by fluorescence microscopy
following urea induction, and the fluorescence intensity of GFP in cell
lysates was measured by spectrophotofluorimetry. P. mirabilis HI4320 carrying the UreD-GFP fusion plasmid was
transurethrally inoculated into the bladders of CBA mice. One week
postchallenge, fluorescent bacteria were detected in thin sections of
both bladder and kidney samples; the fluorescence intensity of bacteria
in bladder tissue was higher than that in the kidney. Kidneys were
primarily infected with single-cell-form fluorescent bacteria, while
aggregated bacterial clusters were observed in the bladder. Elongated
swarmer cells were only rarely observed. These observations demonstrate
that urease is expressed in vivo and that using GFP as a reporter
protein is a viable approach to investigate in vivo expression of
P. mirabilis virulence genes in experimental urinary tract
infection.
 |
INTRODUCTION |
Urinary tract infection (UTI) with
Proteus mirabilis may lead to serious complications that
include renal stones, acute pyelonephritis, catheter obstruction, and
bacteremia (20, 35, 39). Urease is recognized as a major
virulence factor for P. mirabilis by virtue of its ability
to rapidly generate ammonia from the hydrolysis of urea present at 400 to 500 mM in urine (13). Elevated pH results in ion
precipitation in the form of struvite or carbonate-apatite kidney or
bladder stones. Ammonia may also have a direct cytotoxic effect upon
kidney cells in cultures (13, 23, 30, 32-34). Production of
urease appears to be one reason that Proteus infections cause more severe histological damage than Escherichia coli
infections (20, 35, 40).
P. mirabilis urease, a nickel-metalloenzyme, resides in the
cytosol of the bacterium (21). The urease gene cluster is
comprised of eight contiguous genes. The structural genes,
ureABC, which encode subunits of the enzyme, are flanked
immediately upstream by the ureD and downstream by the
ureEFG genes. These seven genes are transcribed on the same
mRNA transcript (18, 21, 22, 37). The four accessory genes
(ureDEFG) are necessary for the insertion of nickel ions
into the apoenzyme and required for assembly of a catalytically active
urease. The ureR gene lies 400 bp upstream of
ureD, is oriented opposite the other seven genes, and acts as a positive regulator in the presence of urea to activate
transcription of urease structural and accessory genes via sequences
upstream of ureD (36).
To evaluate the contribution of urease to virulence, a urease-negative
mutant was previously constructed and the virulence was analyzed by our
lab, using the CBA mouse model of ascending UTI (20, 23).
After 48 h of infection, the number of mutant bacteria recovered
from urine, bladder, and both kidneys was significantly (100-fold)
lower than that of the parent strain. After 1 week of infection, the
mutant concentration was 1 million times less than that of the parent,
which produced significantly more severe pathology than the mutant. The
urease-negative mutant had a 50% infective dose of >2.7 × 109 CFU, a value more than 1,000-fold greater than that of
the parent strain (2.2 × 106 CFU).
To assess urease expression in situ, green fluorescent protein (GFP)
from Aequorea victoria was used as a reporter protein in
this study. In comparison with products of other reporter genes (e.g.,
lacZ, lux, or cat), GFP does not
require addition of a cofactor or substrate to permit observation of
its expression, merely excitation with UV light. GFP is stable in
bacterial cells, is not photobleached by prolonged exposure to UV
light, and does not require lysis of bacterial or host cell for
accurate detection (7, 11, 24, 38). The GFP variant used in
these studies [GFP(S65T/V68L/S72A)] has its peak excitation band
shifted from the wild-type position of 395 nm (470-nm shoulder) to 481 nm, as well as improved folding efficiency (9).
Consequently, it exhibits enhanced brightness when expressed in
bacteria compared to the wild-type protein (9). The emission
maximum of the mutant GFP is 507 nm.
For studies of pathogenic bacteria, GFP has thus far been used to
assess whether promoters are active in mycobacteria (11, 25)
or Salmonella typhimurium (41, 43) within
macrophages. S. typhimurium and Yersinia
pseudotuberculosis expressing GFP have been sorted by
fluorescence-activated cell sorting (42, 43). As well,
bacterium-plant interactions (12), aquatic survival (26), and other applications (28) have been
studied by using GFP expression. In our study, an in-frame UreD-GFP
translational fusion was constructed and fluorescent bacteria from both
in vitro cultures and tissue from experimentally challenged mice were
detected by fluorescence microscopy. We examined the feasibility of
studying gene expression by using GFP in an experimental infection
model of ascending UTI.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and media.
P. mirabilis
HI4320 (urease positive; produces MR/P, Pmf, and ATF fimbriae;
hemolysin positive) was isolated from an elderly woman with urinary
catheter-associated bacteriuria (34). E. coli
DH5
[supE44
lacU169 (
80lacZ
M15)
hsdR17 recA1 endA1 gyrA96 thi-1 relA1] was used as a
recipient for transformations. Luria broth (10 g of tryptone, 5 g
of yeast extract, and 10 g of NaCl per liter) and L agar (Luria
broth containing 1.5% agar) were used as culture media. Nonswarming
agar (10 g of tryptone, 5 g of yeast extract, 5 ml of glycerol,
0.4 g of NaCl, and 29 g of agar per liter) was used to
prevent swarming of P. mirabilis (6). The mutant
gfp gene was kindly provided by B. Cormack (Stanford University).
Recombinant DNA techniques.
Chromosomal DNA was isolated by
the method of Maniatis et al. (27). Plasmid DNA was isolated
by using Qiagen columns as specified by the manufacturer (Qiagen,
Inc.). Electroporation, transformation, and other genetic techniques
were performed by standard methods (4, 27) or according to
manufacturers' instructions.
Nucleotide sequencing.
Sequencing was performed by the
dideoxy-chain termination method (4, 27) with
double-stranded DNA as the template. Reagents from the Prism Ready
Reaction Dye Deoxy Termination kit (Applied Biosystems) were used in
conjunction with Taq polymerase (Boehringer Mannheim
Corporation). Reaction were run on a model 373 DNA sequencer (Applied
Biosystems).
PCR.
PCR was used to amplify gfp sequence from
plasmid pKEN-GFPMut2 (9). Primers were synthesized by the
phosphorimidite method on Applied Biosystems automated DNA synthesizer
(model 380B). Reactions were carried out in a thermocycler (The
Minicycler, model PTC-150-16; MJ Research, Inc.), using Vent DNA
polymerase (Biolabs) or Taq DNA polymerase (Boehringer
Mannheim). The thermocycler was programmed for 30 cycles of 94°C for
45 s, 52°C for 45 s, and 72°C for 45 s. An upstream
primer (5' AGGATCCCTGCAGGTAAAGGAGAAGAACTT 3') contains a
BamHI site and covers sequence encoding the second, third,
and fourth amino acid residues of the N terminus of GFP. The downstream
primer (5' TTGGAATTCTTATTTGTATAGTTCATCC 3') contains an
EcoRI site and includes the sequence encoding the last three residues of the C terminus of GFP. Amplification resulted a 736-bp PCR
product which was ligated into the pCRScript SrfI site.
Western blotting.
Soluble protein from whole-cell French
press lysates of E. coli DH5
or P. mirabilis
HI4320 containing plasmids was electrophoresed on a sodium dodecyl
sulfate (SDS)-12% polyacrylamide gel and transferred to a
polyvinylidene difluoride membrane (Immobilon-P; Millipore). Western
blots were incubated with polyclonal antiserum to GFP (1:10,000;
Clontech) raised in rabbits against recombinant GFP isolated from
transformed E. coli; this was followed by incubation with a
goat anti-rabbit immunoglobulin G (1:2,000; Sigma) coupled to alkaline
phosphatase; the blot was developed with
5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium (Sigma) as a
chromogenic substrate for alkaline phosphatase.
Fluorescence microscopy.
An overnight Luria broth culture of
strains carrying the gfp fusion plasmid was diluted 1:100 in
Luria broth containing ampicillin (50 µg/µl) and grown to an
optical density at 600 nm of 0.1. Bacteria were induced with urea (0 to
500 mM) and harvested after 3 h of additional growth.
For fluorescence microscopy, induced bacteria were washed twice in
phosphate-buffered saline (8 g of NaCl, 0.2 g of KCl, 1.44 g
of Na2HPO4, and 0.24 g of
KH2PO4 per liter [pH 7.4]). A slide was
prepared by air drying a drop of culture on the surface. A Zeiss
Axiophot epifluorescence microscope with filter sets for fluorescein
isothiocyanate fluorescence was used. Images were recorded on
Ektachrome color slide film (ASA 400; Kodak).
Spectrophotofluorimetry.
Bacteria from induced cultures (100 ml) were washed twice in 4 ml of 10 mM Tris-HCl (pH 7.4)-100 mM
NaCl-1 mM MgCl2-10 mM dithiothreitol and suspended in 4 ml of the buffer. Cells were lysed in a French pressure cell (20,000 lb/in2), and the lysate was centrifuged (5,000 × g, 5 min, 4°C). The supernatant was collected and
centrifuged (27,000 × g, 15 min, 4°C)
(7). The emission (470-nm excitation wavelength, emission at
490 to 590 nm, 2-nm slits) and corrected excitation (330 to 530-nm
excitation wavelength, emission at 550 nm) spectra of the supernatant
from the high-speed centrifugation were obtained on a Spectronics AB-2
spectrophotofluorimeter (Spectronics, Inc., Rochester, N.Y.).
CBA mouse model of ascending UTI.
A modification
(19) of the mouse model of ascending UTI originally
developed by Hagberg et al. (14) was used. Female mice (20 to 22 g, 6 to 8 weeks old; Jackson Laboratory, Bar Harbor, Maine)
tested for the absence of bacteriuria were anesthetized with
methoxyflurane and inoculated with P. mirabilis HI4320
(107 CFU suspended in 0.05 ml of phosphate-buffered saline)
through a sterile polyethylene catheter inserted into the bladder
through the urethra. Mice were provided with drinking water containing ampicillin (250 µg/ml). After 1 week, the mice were sacrificed by
administration of an overdose of methoxyflurane. Urine was collected,
and the bladder and both kidneys were removed. Half of the bladder or
kidney samples were embedded in OCT (Tissue-Tek; Miles Inc.), frozen on
dry ice, and cryosectioned into 5- to 10-µm sections for fluorescence
microscopic analysis. The remaining half of each sample was
quantitatively cultured, and viable counts were determined as
CFU/milliliter of urine or CFU/gram of tissue.
 |
RESULTS |
Construction of ureD-gfp translational fusion.
Urease expression is regulated at the transcriptional level.
ureD is upstream of structural subunits ureABC
and is transcribed on the same mRNA as ureABC, under control
of the same promoter (18, 22, 37) (Fig.
1). Thus, the level of UreD-GFP
expression reflects urease apoenzyme expression. Full-length
ureR and the first 108 bp of ureD were cloned on
an EcoRI/BamHI fragment from pMIR10DZ
(18), which is a subclone of pMID1010, into pBluescript to
form pURE-RD. A fragment carrying the gfp open reading frame amplified by PCR from pGFPmut2 (9) was cloned into
pCRScript; the BamHI fragment from this plasmid was isolated
and ligated into BamHI-digested pURE-RD. The resultant
plasmid, designated pURE-RD-GFP (Fig. 1), was isolated, and insertion
of the proper fragment was confirmed by restriction enzyme digestion.
The in-frame translational fusion was confirmed by nucleotide
sequencing of the junction (data not shown).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Construction of a ureD-gfp fusion. Intact
ureR and part of ureD were cloned as an
EcoRI/BamHI fragment from pMIR10DZ
(18), which is a subclone of pMID1010, into pBluescript to
form pURE-RD. A fragment carrying the gfp open reading frame
(see text) amplified by PCR from pGFPmut2 (9) was cloned
into pCRScript; the BamHI fragment from this plasmid was
isolated and ligated into BamHI-digested pURE-RD. The final
construct was designated pURE-RD-GFP.
|
|
Urea induction and Western blotting.
To demonstrate that
synthesis of UreD-GFP could be induced by urea, E. coli
DH5
(pURE-RD-GFP) was grown in Luria broth at 37°C. When
exponentially growing cultures reached an optical density at 600 nm of
0.1, urea (0 to 500 mM) was added. After 2 h of induction, bacteria were collected and lysed by passage through a French pressure
cell. Western blots of soluble protein were used to assess expression
of the UreD-GFP fusion. Soluble protein from either E. coli
DH5
or P. mirabilis HI4320 transformed with pURE-RD-GFP, induced or uninduced by urea, was electrophoresed on an SDS-12% polyacrylamide gel. Proteins were transferred to nitrocellulose and
reacted with rabbit anti-GFP. The UreD-GFP fusion protein was predicted
to contain the first 37 amino acids of UreD and all but the first two
of a total of 238 amino acids of GFP. The fusion protein, therefore,
was predicted to contain 275 amino acids and have a molecular size of
30.0 kDa. Western blot analysis showed that urea-induced E. coli(pURE-RD-GFP) cells produced a polypeptide of 30 kDa,
consistent with the predicted size (Fig. 2A). The expression level correlated with
the urea concentration, with maximal induction at 200 and 500 mM. The
band was missing from the uninduced sample, indicating that the
induction of fusion GFP synthesis occurs only in the presence of urea
in a E. coli background. Although P. mirabilis(pURE-RD-GFP) exhibited similar urea
concentration-dependent expression, it also produced a low level of
UreD-GFP fusion protein in the absence of urea (Fig. 2B).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Western blot analysis of UreD-GFP fusion protein
induction by urea. E. coli (A) and P. mirabilis
(B) carrying pURE-RD-GFP were uninduced or induced by urea (10, 50, 100, 200, and 500 mM). Soluble protein from these strains was
electrophoresed on an SDS-12% polyacrylamide gel. A polyclonal
antiserum raised in rabbits against recombinant GFP was used for
Western blotting.
|
|
Fluorescence determination of GFP expression.
The level of
UreD-GFP fusion protein expression was also quantitated by
spectrophotofluorimetry. Soluble cell extracts were prepared from
uninduced or urea-induced (50 and 250 mM) bacterial cultures. Both
fluorescence excitation (data not shown) and emission spectra of the
induced soluble cell extracts from E. coli (Fig. 3A) and P. mirabilis (Fig. 3B)
were very similar to those observed previously for this GFP variant
(9), suggesting that GFP had indeed been expressed. Upon
induction, both species exhibited dramatic, urea-dependent increases in
fluorescence compared with the corresponding uninduced strains. In
particular, E. coli displayed a 33-fold increase in
intensity at 509 nm when induced with 50 mM urea and a 50-fold increase
when induced with 250 mM urea (Fig. 3A). Similarly, P. mirabilis exhibited a fourfold increase in emission at 509 nm when
induced with 250 mM urea and a negligible change in emission when
induced with 50 mM urea (Fig. 3B). The differences in the degree of
fluorescence enhancement are attributable to both lower fluorescence
background in E. coli and more substantial expression of
GFP.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Fluorescence emission spectra of soluble extracts from
E. coli DH5 (pURE-RD-GFP) (A) and P. mirabilis
HI4320(pURE-RD-GFP) (B). Bacteria were induced with 0 ( ), 50 (  ), and 250 (---) mM urea.
|
|
Visible fluorescence of bacteria after urea induction.
Following urea induction in vitro, E. coli(pURED-GFP) and
P. mirabilis(pURED-GFP) were also quantitatively assessed by
fluorescence microscopy. For E. coli containing the
construct, without induction there were no visible fluorescent
bacteria. At 10 mM urea, all bacteria were very weakly fluorescent; at
100 mM, all bacteria were brightly fluorescent. For P. mirabilis containing the construct, without induction, the vast
majority of bacteria showed no fluorescence; a very small percentage of
bacteria, however, were brightly fluorescent. At 10 mM urea, all of the
bacteria were at least weakly fluorescent and some were brightly
fluorescent; at
100 mM, all bacteria were brightly fluorescent but
did not display the same intensity as did the transformed E. coli.
In vivo expression of GFP in experimental ascending UTI.
To
determine whether GFP could be used as a reporter for urease expression
in vivo and whether the expression level was sufficient during
infection to visualize bacteria, CBA mice were inoculated transurethrally with 107 CFU of P. mirabilis
HI4320(pURED-GFP). After 1 week, the geometric means of
log10 concentrations of bacteria in urine, bladder, and kidney were determined and found to be typical of previous experimental infections (5): urine, 7.79 CFU/ml; bladder, 6.22 CFU/g; and kidneys, 5.15 CFU/g. Thus, GFP expression did not compromise survival of the challenge strains.
To search for fluorescent bacteria, frozen thin-sectioned bladder (Fig.
4A to
H) or kidney (Fig. 4I to K) samples from infected animals were observed
by fluorescence microscopy. Numerous green fluorescent bacteria were
detected in both bladder and kidney samples. The fluorescence intensity
of bacteria from bladder appeared qualitatively higher than that from
kidney, suggesting a higher level urease expression in bladder than in
kidney. While some single bacteria attached to the surface of bladder
epithelium by the pole of the organism (Fig. 4G), other aggregated
bacteria, apparently covered in biofilm, were loosely attached to the
bladder tissue (Fig. 4D and E). Such large aggregates were commonly
observed in the bladder. While an occasional elongated swarmer cell was observed in the bladder sections (Fig. 4B and C), only single vegetative forms of bacteria were found scattered around the kidney tissue samples. The results clearly indicate that the urea
concentration was high enough to induce the GFP-UreD fusion protein
levels sufficient to make individual bacteria easily visible by
fluorescence microscopy.

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 4.
In vivo expression of UreD-GFP by P. mirabilis infecting the bladders and kidneys of CBA mice. Thin
sections of bladders (A to H) and kidneys (I to K) obtained from CBA
mice infected with P. mirabilis HI4320(pURE-RD-GFP) were
observed by fluorescence microscopy. Fluorescent bacteria are
identified by arrows. (F and H) Phase-contrast images of panels E and
G, respectively.
|
|
 |
DISCUSSION |
An in-frame translational fusion of ureD with
gfp (S65T/V68L/S72A) was successfully constructed and
confirmed by nucleotide sequencing of the fusion junction. Using
Western blotting and spectrophotofluorimetry, we found expression of
UreD-GFP only in the samples with urea induction in E. coli;
the expression level was correlated with urea concentration, with
highest induction at 200 to 500 mM, an observation consistent with
previous reports (37). We have learned that urease genes are
indeed expressed in vivo by P. mirabilis during UTI,
confirming an assertion for which significant circumstantial evidence
exists. More importantly, however, we have demonstrated that GFP can be
used successfully to study expression of virulence genes in an
experimental model of ascending UTI.
While we are confident that expression of the fusion protein represents
an accurate proxy for measurement of urease activity, it should be
stressed that we are measuring expression of ureD (encodes
an accessory protein that is not part of the enzyme), a gene directly
upstream of ureA (encodes the smallest subunit of the
apoenzyme) (Fig. 1). It has been determined previously that
ureD and ureA are transcribed on the same
urea-inducible mRNA (18, 21, 22, 37). Nevertheless,
expression of the UreD-GFP fusion is an indirect measurement of urease
enzyme expression.
In these studies, we noted that uninduced cultures of P. mirabilis(pURED-GFP) produced a low level of the fusion protein
whereas E. coli carrying the same multicopy plasmid
maintains tight regulation of enzyme synthesis in the absence of urea.
This was observed both on Western blots (Fig. 2) and by
spectrophotofluorimetry (Fig. 3) (compare levels of uninduced
production of fusion proteins and fluorescence intensity for P. mirabilis and E. coli). This finding is consistent with
the fact that uninduced P. mirabilis produces a low level of
urease (21, 31). These observations suggest that P. mirabilis may have an additional tier of regulation beyond
UreR-mediated transcriptional activation. Allison et al. (3)
provided evidence for this reporting that expression of urease-specific
mRNA is increased during swarming, suggesting that expression of urease
goes beyond simple urea induction. Indeed, it is logical to always
produce some enzyme; a low level of urease may be necessary for
adequate nitrogen metabolism in P. mirabilis in the bowel or
outside the host. In some bacterial species, like Morganella
morganii, urease is synthesized constitutively to ensure that some
enzyme is always produced (17).
Before the S65T/V68L/S72A variant of gfp was available, both
wild-type gfp and gfp (S65T) (8, 15)
were fused by us to ureD (data not shown). In both cases,
however, no strong fluorescence emitted from either E. coli
or P. mirabilis carrying the pURED-GFP plasmid could be
observed by fluorescence microscopy or spectrophotofluorimetry. Therefore, we looked for expression of the GFP fusion protein in
whole-cell extract by Western blotting using polyclonal anti-GFP. Western blotting demonstrated that the fusion protein was expressed and
that levels of induction correlated with urea concentration. However,
by separating inclusion bodies from whole-cell extract, we noted that
most of the fusion protein partitioned with the inclusion bodies. This
finding is consistent with what has been reported by several groups,
specifically that overexpressed GFP in inclusion bodies of bacteria
does not generate the internal chromophore and is therefore
nonfluorescent (16). The newest variant of gfp
(S65T/V68L/S72A) appears to overcome the folding problem in bacteria
and also has increased fluorescence intensity. Therefore, this version
of GFP, unlike previous versions, is suitable for in vivo studies in
the urinary tract.
In vivo expression of UreD-GFP was assessed in experimental ascending
UTI. Urea output in mouse urine (24.3 mg/24 h; range of volume, 0.9 to
2.9 ml; therefore, the urea concentration range is 140 to 450 mM
[10]) is similar to that of humans and is high enough
to fully induce GFP in P. mirabilis transformed with
pURED-GFP encoding the translational fusion. Fluorescent bacteria were
detected as single cells in both bladder and kidney, indicating that
the P. mirabilis urease gene was induced in both tissues. In
the bladder, some interesting phenomena were observed. First, adherence
of single bacteria to the bladder epithelium, which may be the first step of colonization of the host, was mediated by one end of the cell,
suggesting the polarized distribution of the adhesin structures or an
intimate attachment by the bacterium. Second, aggregates and multiple
layers of bacteria appeared to be embedded in biofilm (polysaccharide
matrix) that was loosely attached to surface of the bladder epithelium.
Interestingly, bacteria clustered inside a protective biofilm have been
implicated in chronic bacterial UTI and bladder stone formation and may
have the advantage of being more resistant to host defenses and
antibiotic therapy (29, 40). Third, vegetative forms of
P. mirabilis (single bacterial cells as opposed to elongated
swarming cells) were most often observed in the bladder tissue. Fourth,
elongated swarming cells (5 to 10 cell lengths) were occasionally found
in bladder; the role of these cells, however, is unclear. In the
kidneys, extracellular bacteria were fluorescent and tended to remain
as single cells in a vegetative form. Since the fluorescence was
qualitatively weaker in the kidney than in the bladder, this finding
suggested that either the urea concentration was lower in the kidney or that bacteria in the kidney were less accessible to urine because they
had invaded more deeply into tissue. The fact that the elongated swarming cells were not observed in kidneys does not necessarily mean
that swarming cells do not play a role in infection. These cells may
have invaded kidney cells where the urea concentration was too low to
induce the fusion protein (1, 2) and thus make themselves
visible. Nevertheless, we have demonstrated for the first time that the
enhanced GFP can be used to study expression of virulence genes by
P. mirabilis in a mouse model of ascending UTI.
 |
ACKNOWLEDGMENTS |
This work was supported in part by Public Health Service grants
AI23328 and DK47920 from the National Institutes of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201. Phone: (410) 706-0466. Fax:
(410) 706-2129. E-mail: hmobley{at}umabnet.ab.umd.edu.
Editor: J. T. Barbieri
 |
REFERENCES |
| 1.
|
Allison, C.,
N. Coleman,
P. L. Johns, and C. Hughes.
1992.
Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation.
Infect. Immun.
60:4740-4746[Abstract/Free Full Text].
|
| 2.
|
Allison, C.,
L. Emody,
N. Coleman, and C. Hughes.
1994.
The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis.
J. Infect. Dis.
169:1155-1158[Medline].
|
| 3.
|
Allison, C.,
H.-C. Lai, and C. Hughes.
1992.
Co-ordinate expression of virulence genes during swarm cell differentiation and population migration of Proteus mirabilis.
Mol. Microbiol.
6:1583-1591[Medline].
|
| 4.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1995.
.
Current protocols in molecular biology.
John Wiley & Sons, Inc., New York, N.Y.
|
| 5.
|
Bahrani, F. K.,
G. Massad,
C. V. Lockatell,
D. E. Johnson,
R. Russell,
J. W. Warren, and H. L. T. Mobley.
1994.
Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
Infect. Immun.
62:3363-3371[Abstract/Free Full Text].
|
| 6.
|
Belas, R.,
D. Erskine, and D. Flaherty.
1991.
Transposon mutagenesis in Proteus mirabilis.
J. Bacteriol.
173:6289-6293[Abstract/Free Full Text].
|
| 7.
|
Chalfie, M.,
T. Yuan,
G. Euskirchen,
W. W. Ward, and D. C. Prasher.
1994.
Green fluorescent protein as a marker for gene expression.
Science
263:802-805[Abstract/Free Full Text].
|
| 8.
|
Clontech.
1996.
Living colorsTM enhanced GFP vectors.
CLONTECHniques
11(2):2-3.
|
| 9.
|
Cormack, B. P.,
R. H. Valdivia, and S. Falkow.
1996.
FACS-optimized mutants of the green fluorescent protein (GFP).
Gene
173:33-38[Medline].
|
| 10.
|
Crispens, C. G., Jr.
1975.
, p. 130.
Handbook on the laboratory mouse
Charles C Thomas, Springfield, Ill.
|
| 11.
|
Dhandayuthapani, S.,
L. E. Via,
C. A. Thomas,
P. M. Horowitz,
D. Deretic, and V. Deretic.
1995.
Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interaction with macrophages.
Mol. Microbiol.
17:901-912[Medline].
|
| 12.
|
Gage, D. J.,
T. Bobo, and S. R. Long.
1996.
Use of green fluorescence protein to visualize the early events of symbiosis between Rhizobium meliloti and alfalfa.
J. Bacteriol.
178:7159-7166[Abstract/Free Full Text].
|
| 13.
|
Griffith, D. P.,
D. M. Musher, and C. Itin.
1976.
Urease: the primary cause of infection-induced urinary stones.
Invest. Urol.
13:346-350[Medline].
|
| 14.
|
Hagberg, L.,
I. Engberg,
R. Freter,
J. Lam,
S. Olling, and C. Svanborg-Eden.
1983.
Ascending unobstructed urinary tract infection in mice cause by pyelonephritogenic Escherichia coli of human origin.
Infect. Immun.
40:273-283[Abstract/Free Full Text].
|
| 15.
|
Heim, R.,
A. B. Cubitt, and R. Y. Tsien.
1995.
Improved green fluorescence.
Nature
373:663-664[Medline].
|
| 16.
|
Heim, R.,
D. C. Prasher, and R. Y. Tsien.
1994.
Wavelength mutations and posttranslational autoxidation of green fluorescent protein.
Proc. Natl. Acad. Sci. USA
91:12501-12504[Abstract/Free Full Text].
|
| 17.
|
Hu, L.-T.,
E. B. Nicholson,
B. D. Jones,
M. J. Lynch, and H. L. T. Mobley.
1990.
Morganella morganii urease: purification, characterization, and isolation of gene sequences.
J. Bacteriol.
172:3073-3080[Abstract/Free Full Text].
|
| 18.
|
Island, M., and H. L. T. Mobley.
1995.
Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function.
J. Bacteriol.
177:5653-5600[Abstract/Free Full Text].
|
| 19.
|
Johnson, D. E.,
C. V. Lockatell,
M. Hall-Craigs,
H. L. T. Mobley, and J. W. Warren.
1987.
Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients.
J. Urol.
138:632-635[Medline].
|
| 20.
|
Johnson, D. E.,
R. G. Russell,
C. V. Lockatell,
J. C. Zulty,
J. W. Warren, and H. L. T. Mobley.
1993.
Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
Infect. Immun.
61:2748-2754[Abstract/Free Full Text].
|
| 21.
|
Jones, B. D., and H. L. T. Mobley.
1988.
Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes.
J. Bacteriol.
170:3342-3349[Abstract/Free Full Text].
|
| 22.
|
Jones, B. D., and H. L. T. Mobley.
1989.
Proteus mirabilis urease: nucleotide sequence determination and comparison with jack bean urease.
J. Bacteriol.
171:6414-6422[Abstract/Free Full Text].
|
| 23.
|
Jones, B. D.,
C. V. Lockatell,
D. E. Johnson,
J. W. Warren, and H. L. T. Mobley.
1990.
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection.
Infect. Immun.
58:1120-1123[Abstract/Free Full Text].
|
| 24.
|
Kain, S. R.,
M. Adams,
A. Kondepudi,
T. T. Yang,
W. W. Ward, and P. Kitts.
1995.
Green fluorescent protein as a reporter of gene expression and protein localization.
BioTechniques
19:650-655.
[Medline] |
| 25.
|
Kremer, L.,
A. Baulard,
J. Estaquier,
O. Poulain-Godefroy, and C. Locht.
1995.
Green fluorescence protein as a new expression marker in mycobacteria.
Mol. Microbiol.
17:913-922[Medline].
|
| 26.
|
Leff, L. G., and A. A. Leff.
1996.
Use of green fluorescent protein to monitor survival of genetically engineered bacteria in aquatic environments.
Appl. Environ. Microbiol.
62:3486-3488[Abstract].
|
| 27.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 28.
|
Matthysse, A. G.,
S. Stretton,
C. Dandie,
N. C. McClure, and A. E. Goodman.
1996.
Construction of GFP vectors for use in gram-negative bacteria other than E. coli.
FEMS Microbiol. Lett.
145:87-94[Medline].
|
| 29.
|
McLean, R. J. C.,
J. A. Downey,
A. L. Lablans,
J. M. Clark,
A. J. Dumanski, and J. C. Nickel.
1992.
Modeling biofilm-associated urinary tract infections in animals.
Int. J. Biodeterior. Biodegrad.
30:201-216.
|
| 30.
|
Mobley, H. L. T., and G. R. Chippendale.
1990.
Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
J. Infect. Dis.
161:525-530[Medline].
|
| 31.
|
Mobley, H. L. T.,
G. R. Chippendale,
K. G. Swihart, and R. Welch.
1991.
Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.
Infect. Immun.
59:2036-2042[Abstract/Free Full Text].
|
| 32.
|
Mobley, H. L. T.,
M. D. Island, and R. P. Hausinger.
1995.
Molecular biology of microbial urease.
Microbiol. Rev.
59:451-480[Abstract/Free Full Text].
|
| 33.
|
Mobley, H. L. T., and R. P. Hausinger.
1989.
Microbial ureases: significance, regulation, and molecular characterization.
Microbiol. Rev.
53:85-108[Abstract/Free Full Text].
|
| 34.
|
Mobley, H. L. T., and J. W. Warren.
1987.
Urease positive bacteriuria and obstruction of long term urinary catheters.
J. Clin. Microbiol.
25:2216-2219[Abstract/Free Full Text].
|
| 35.
|
Mobley, H. L. T.
1996.
Virulence of Proteus mirabilis, p. 245-271. In
H. L. T. Mobley, and J. W. Warren (ed.), Urinary tract infection: molecular pathogenesis and clinical management.
ASM Press, Washington, D.C.
|
| 36.
|
Nicholson, E. B.,
E. A. Concaugh,
P. A. Foxall,
M. D. Island, and H. L. T. Mobley.
1993.
Proteus mirabilis urease: transcriptional regulation by ureR.
J. Bacteriol.
175:465-473[Abstract/Free Full Text].
|
| 37.
|
Nicholson, E. B.,
E. A. Concaugh, and H. L. T. Mobley.
1991.
Proteus mirabilis urease: use of a ureA-lacZ fusion demonstrates that induction is highly specific for urea.
Infect. Immun.
64:5332-5340[Abstract].
|
| 38.
|
Prasher, D. C.,
V. K. Eckenrode,
W. W. Ward, and F. G. Prendergast.
1992.
Primary structure of the Aequorea victoria green fluorescent protein.
Gene
111:229-233[Medline].
|
| 39.
|
Rubin, R.,
N. Tolkoff-Rubin, and R. Cotran.
1986.
Urinary tract infection, pyelonephrititis and reflux nephropathy, p. 1085-1141. In
G. Brenner, and F. Rector, Jr. (ed.), The kidney, 3rd ed.
The W. B. Saunders Co., Philadelphia, Pa.
|
| 40.
|
Salyers, A. A., and D. D. Whitt.
1994.
Host defenses against bacterial-pathogens: defenses of body surfaces, p. 3-15. In
A. A. Salyers, and D. D. Whitt (ed.), Bacterial pathogenesis: a molecular approach.
ASM Press, Washington, D.C.
|
| 41.
|
Valdivia, R. H., and S. Falkow.
1997.
Fluorescence-based isolation of bacterial genes expressed within host cells.
Science
277:2007-2011[Abstract/Free Full Text].
|
| 42.
|
Valdivia, R. H.,
A. E. Hromockyj,
D. Monack,
L. Ramakrishnan, and S. Falkow.
1996.
Applications for green fluorescent protein (GFP) in the study of host-pathogen interaction.
Gene
173:47-52[Medline].
|
| 43.
|
Valdivia, R. H., and S. Falkow.
1996.
Bacterial genetics by flow cytometry: rapid isolation of Salmonella typhimurium acid-inducible promoters by differential fluorescence induction.
Mol. Microbiol.
22:367-378[Medline].
|
Infect Immun, January 1998, p. 330-335, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Brehm-Stecher, B. F., Johnson, E. A.
(2004). Single-Cell Microbiology: Tools, Technologies, and Applications. Microbiol. Mol. Biol. Rev.
68: 538-559
[Abstract]
[Full Text]
-
Jansen, A. M., Lockatell, C. V., Johnson, D. E., Mobley, H. L. T.
(2003). Visualization of Proteus mirabilis Morphotypes in the Urinary Tract: the Elongated Swarmer Cell Is Rarely Observed in Ascending Urinary Tract Infection. Infect. Immun.
71: 3607-3613
[Abstract]
[Full Text]
-
Leveau, J. H. J., Lindow, S. E.
(2001). Predictive and Interpretive Simulation of Green Fluorescent Protein Expression in Reporter Bacteria. J. Bacteriol.
183: 6752-6762
[Abstract]
[Full Text]